Examples of targets used in FME are epidermal growth factor receptor (EGFR, overexpressed in colorectal cancer) and vascular endothelial growth factor A (VEGFA, present in early stages of colorectal neoplasms and Barrett’s dysplasia) [13, 23]. Here, VEGFA is linked to colorectal cancer.